What is the name of the lobe that controls visual processing?

Questions 95

ATI RN

ATI RN Test Bank

Use of Psychotropic Medications Questions

Question 1 of 5

What is the name of the lobe that controls visual processing?

Correct Answer: C

Rationale: The correct answer is C: Occipital Lobe. This lobe is responsible for visual processing, interpreting visual information such as shapes, colors, and motion. It contains the primary visual cortex, which plays a crucial role in processing visual stimuli. The other choices are incorrect because A: Gyrus is a raised fold in the brain's surface, B: Frontal Lobe is primarily responsible for executive functions and motor skills, and D: Parietal Lobe is involved in sensory processing and spatial awareness.

Question 2 of 5

What is the expected outcome for a patient who is considered a "intermediate metabolizer"?

Correct Answer: B

Rationale: As an intermediate metabolizer, the patient may have variations in drug metabolism, leading to altered drug levels and potentially increased risk for drug-drug interactions. This is due to slower or inefficient metabolism of certain medications, which can result in drug accumulation and adverse effects when combined with other drugs. Therefore, the correct answer is B. The other choices are incorrect because: A: Incorrect - Intermediate metabolizers may still require medication dosage adjustments. C: Incorrect - Providers may need to decrease, not increase, drug dosages for intermediate metabolizers. D: Incorrect - Intermediate metabolizers may experience subtherapeutic effects due to variability in drug metabolism.

Question 3 of 5

Ethical issues within mental health include which of the following?

Correct Answer: A

Rationale: The correct answer is A because the patient's inability to afford medication poses a significant ethical issue in mental health. This impacts the patient's access to necessary treatment and may lead to disparities in care. Choice B focuses on autonomy, which is important but not specifically related to ethical issues. Choice C pertains to cultural competence, which is important but not inherently an ethical issue. Choice D involves patient preferences in treatment planning, which is valuable but not directly related to ethical concerns surrounding access to medication.

Question 4 of 5

SSRIs, SNRIs, and tricyclic antidepressants increase levels of which neu- rotransmitter?

Correct Answer: B

Rationale: The correct answer is B: Serotonin. SSRIs, SNRIs, and tricyclic antidepressants work by inhibiting the reuptake of serotonin, leading to increased levels of this neurotransmitter in the synaptic cleft. This increase in serotonin helps regulate mood and emotions, making it an effective treatment for depression. Dopamine, GABA, and Glutamate are not primarily affected by these antidepressants, making them incorrect choices.

Question 5 of 5

Which neurotransmitter in considered the chief inhibitory neurotransmit- ter?

Correct Answer: C

Rationale: The correct answer is C: GABA. GABA (Gamma-aminobutyric acid) is the chief inhibitory neurotransmitter in the central nervous system. It works by reducing the activity of neurons, leading to a calming effect. Histamine (A) is involved in the sleep-wake cycle, dopamine (B) is associated with reward and motivation, and glutamate (D) is the primary excitatory neurotransmitter in the brain. Therefore, GABA is the correct answer as it plays a crucial role in inhibiting neural activity.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions